Drugs at age 17 - Trends, use context and risk-ranking
Tendances n° 49, OFDT, 4 p.
The 2005 ESCAPAD survey (Survey on Health and Consumption on Call-up and Preparation for Defence Day) is the fifth nationwide survey of its kind to be organised. The survey completes the device introduced by OFTD in order to monitor usage throughout the adult population (the Baromètre Santé or "Health Barometer" organised under the scientific supervision of the Inpes), and the ESPAD project organised among the school-age population (the European School Survey Project on Alcohol and other Drugs, in collaboration with the Inserm). It covers mainland France but also the overseas départements and local authorities, using the same methodology for each. The data from the 2005 survey was drawn from the replies of 29,393 young people in mainland France aged 17 years old at the time the survey was carried out. It makes it possible to describe trends over five years but also includes new questions concerning the context of alcohol and cannabis use, the driving of a motor vehicle under the influence and accidents related to the consumption of these products. Finally, thanks to the introduction of a new question, cannabis sourcing methods can now also be identified and recorded.
François Beck, Stéphane Legleye, Stanislas Spilka
Download the PDF file (129 Ko)
Drugs in Europe
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.